ArticleScientific reports2025
Simultaneous quantification of five bioactive markers for standardization of ayurvedic polyherbal formulation Jwarahara Kwatha Choornam using HPTLC.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Jwarahara Kwatha Choornam (JKC) is a polyherbal coded Ayurvedic formulation developed by the Central Council for Research in Ayurvedic Sciences (CCRAS), New Delhi, India. Traditionally used for managing chronic fever, cold, and malaria, JKC has gained recognition for its therapeutic benefits, such as enhancing digestion, stimulating appetite, detoxifying blood, modulating the immune response, and offering protection against common bacterial infections. The medicinal plant used in JKC is widely utilized by Ayurvedic practitioners and the general population in the Kerala region, where it holds a longstanding place in traditional health practices. Notably, during the COVID-19 pandemic, both practitioners and users have reported the formulation's supportive role in treatment, further highlighting its therapeutic relevance. To ensure the quality, safety, and efficacy of this important Ayurvedic preparation, CCRAS has undertaken standardization efforts, including the development of a novel High-Performance Thin-Layer Chromatography (HPTLC) method for the simultaneous estimation of five key bioactive marker compounds. The study establishes a robust High-Performance Thin-Layer Chromatography (HPTLC) method for the simultaneous estimation of five key bioactive markers-Andrographolide (AG), Piperine (PP), Picroside-I (P-I), Picroside-II (P-II), and α-Cyperone (AC) present in the plants Andrographis paniculata, Cyperus rotundus, Piper longum, Piper nigrum, Zingiber officinale, Hedyotis corymbosa, and Picrorhiza kurroa. Used in the Jwarahara Kwatha Choornam (JKC) formulation. Effective separation of these compounds was achieved using a carefully optimized mobile phase comprising Toluene, Ethyl Acetate, Methanol, and Formic Acid in a 4:4:1:1 (v/v/v/v) ratio. The developed HPTLC method, resolved the five targeted bioactive markers-Andrographolide (AG), Piperine (PP), Picroside-I (P-I), Picroside-II (P-II), and α-Cyperone (AC)-with distinct R
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.